Friday 6 November 2026 Export RPRX’s income statement to Excel — free account

Royalty Pharma PLC

RPRX Healthcare Biotechnology

Royalty Pharma PLC’s revenue for fiscal 2025 (year ended December 2025) was $2.4 billion, up 5.06% from fiscal 2024.

Revenue: +13.3%
EPS: −51.5%
Free cash flow: +364.6%
Total debt: −4.00%

Quarter to September 2026, against a year earlier

Dividend growth 5 yrs

67.90 0.33 +0.49%

Follow RPRX

Alert me

Market cap: $39.0B
P/E: 44.8×
Fwd P/E: 27.3×
Dividend yield: 1.37%
F-score: 5/9
Altman Z: 1.61
Beneish M: −2.83
Dividend safety: 41/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Royalty Pharma PLC (RPRX) Current ratio

Alert me on Current ratio

Royalty Pharma PLC's current ratio at the end of the quarter to 30 September 2026 was 1.3×, down 1.1× from fiscal 2025 (2.4×). Over the past ten years it has ranged from 1.4× (fiscal 2024) to 16.8× (fiscal 2021); the current reading is higher than 43% of that period. That is below the Biotechnology industry median of 4.9× and below the Healthcare sector median of 3.1×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/RPRX/current-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Royalty Pharma PLC current ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/RPRX/metrics/current-ratio">Royalty Pharma PLC (RPRX) current ratio — stockrow.com</a></p>

Period	Current ratio	Change
FY2025	2.4×	67.08%
FY2024	1.4×	(81.79%)
FY2023	7.9×	260.59%
FY2022	2.2×	(86.97%)
FY2021	16.8×	91.88%
FY2020	8.8×	250.99%
FY2019	2.5×	—

Period	Current ratio	Change
Sep 2026	1.3×	(53.74%)
Jun 2026	2.8×	5.08%
Mar 2026	2.7×	10.82%
Dec 2025	2.4×	(31.07%)
23 more quarters	Free account

Against its own ten years

Low 1.4× High 16.8×

Ten-year median 2.5×

Current reading's percentile 43

Company	Current ratio
ROIV Roivant Sciences Ltd. compare	16.7×
BNTX BioNTech SE Sponsored ADR compare	8.6×
RVMD Revolution Medicines, Inc. compare	8.4×
ARGX argenex SE compare	5.1×
INCY Incyte Corporation compare	3.8×
ONC BeOne Medicines Ltd. - Sponsored ADR compare	3.6×
INSM Insmed, Inc. compare	2.9×
GMAB Genmab A/S Sponsored ADR compare	2.5×
RPRX Royalty Pharma PLC	1.3×
Biotechnology industry median	4.9×
Healthcare sector median	3.1×
Market median	1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

Royalty Pharma PLC (RPRX) Current ratio

Current ratio, annual

Annual newest first

Quarterly newest first

Against its own ten years

Current ratio against peers

What Current ratio is

More on RPRX

Current ratio, annual

Annual newest first

Quarterly newest first

Against its own ten years

Current ratio against peers

What Current ratio is

More on RPRX

Stockrow Weekly